Aesopra

Main information

  • Trade name:
  • Aesopra 40 mg Powder For Injection (I.V.)
  • Dosage:
  • 40 mg
  • Pharmaceutical form:
  • Powder For Injection (I.V.)
  • Units in package:
  • 10 mL USP Type 1 Amber Tubular Vial + (diluent) 5 mL Sodium Chloride
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug
  • Manufactured by:
  • Gufic Biosciences

Documents

Localization

  • Available in:
  • Aesopra 40 mg Powder For Injection (I.V.)
    Philippines
  • Language:
  • English

Status

  • Source:
  • FDA - Food And Drug Administration - Philippines
  • Authorization number:
  • DRP-4015-02
  • Authorization date:
  • 12-10-2022
  • Last update:
  • 06-04-2018